Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to investigate, for the first time, whether gut bacteria composition and function of patients with CRPS differ from those of healthy adults. Samples of stool, urine and blood will be collected from patients with CRPS and from healthy adults. The type and function of bacteria of CRPS patients will be analyzed and compared to those of healthy adults to test if potential differences could explain the mechanism/s involved with the development of CRPS.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05473338
Study type Observational
Source McGill University Health Centre/Research Institute of the McGill University Health Centre
Contact
Status Active, not recruiting
Phase
Start date April 14, 2022
Completion date June 30, 2024

See also
  Status Clinical Trial Phase
Recruiting NCT00377468 - Effect of Delta-9-Tetrahydrocannabinol on the Prevention of Chronic Pain in Patients With Acute CRPS (ETIC-Study) Phase 2
Completed NCT01618578 - The Rubber Hand Illusion (RHI) in Patients With CRPS N/A
Completed NCT02467556 - Psychological Intervention and Physiotherapy With Medication Improves CRPS Patients Outcome Phase 4
Withdrawn NCT02031211 - TNF-alpha Inhibition in CRPS: A Randomized Controlled Trial N/A
Recruiting NCT01601925 - Distances From Cricoid Cartilage to the Targets of Stellate Ganglion Block N/A
Withdrawn NCT04709757 - Comparison of Continuous and Burst High Frequency Spinal Cord Stimulation Paradigms N/A
Completed NCT00558753 - Prospective, Randomized Controlled Trial on Perioperative Pregabalin to Reduce Late-onset CRPS After TKA Phase 2